Lv51
840 积分 2023-07-23 加入
Host Natural Killer T Cells Regulate Allogeneic Donor CD8+ T Cell Expression of Homing and Chemokine Receptors and Tissue Migration
1个月前
已关闭
Melphalan-based conditioning with post-transplant cyclophosphamide for peripheral blood stem cell transplantation: donor effect
2个月前
已完结
Clinical-genomic profiling of MDS to inform allo-HSCT:Recommendations from an international panel on behalf of the EBMT
2个月前
已完结
Comparable relapse incidence after unrelated allogeneic stem cell transplantation with post‐transplant cyclophosphamide versus conventional anti‐graft versus host disease prophylaxis in patients with acute myeloid leukemia: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
4个月前
已完结
Does IPSS-R down staging before transplantation improve the prognosis of patients with Myelodysplastic neoplasms?
4个月前
已关闭
Donor and recipient age, gender and ABO incompatibility regardless of donor source: validated criteria for donor selection for haematopoietic transplants
4个月前
已完结
How I reduce and treat posttransplant relapse of MDS
4个月前
已关闭
Effect of donor type in patients with AML or MDS undergoing reduced intensity hematopoietic cell transplant
4个月前
已关闭
Impact of post-transplant cyclophosphamide (PTCy)-based prophylaxis in matched sibling donor allogeneic haematopoietic cell transplantation for patients with myelodysplastic syndrome: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
4个月前
已完结
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelodysplastic Syndromes (MDS)
4个月前
已关闭
皖公网安备34019202002308
